BRAF mutation correlates with distinct histopathologic features, such as intraepidermal melanoma nest formation and a larger rounder border of the tumor with surrounding skin, suggesting surrogate markers can be used to select cases for molecular testing [19]. The gene discussed is BRAF; the disease is melanoma.